CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Carvolix is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Carvolix
320 avenue Archimede
Les pleiades III Batiment B
Phone: +33 442951220p:+33 442951220 AIX-EN-PROVENCE, 13100  France Ticker: CVXCVX
Business Summary
Carvolix is a France-based company. The Company is engaged in developing Artificial Intelligence (AI)-driven autonomous mini-robots and biomimetic implants for interventional cardiology and stroke treatment. It operates through the consolidation, Caranx Medical, and Artedrone, and focuses on technologies used in cardiac valve replacement, structural heart interventions, and neurovascular procedures. It develops systems combining micro-robotics, artificial intelligence, imaging guidance, and implantable heart devices. Its product portfolio includes the TAVIPILOT software for transcatheter aortic valve implantation (TAVI), structural heart devices such as Kalios and Epygon, the Artus artificial urinary sphincter, and a robotic platform intended for stroke treatment.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MichelTherin 77 1/1/2023 8/22/2022
Chief Executive Officer SebastienLadet 1/1/2024 8/22/2022
Chief Financial Officer Christophede Vregille 7/17/2023 7/17/2023
12 additional Officers and Directors records available in full report.

Business Names
Business Name
AFME
ALAM
CVX

General Information
Number of Employees: 76 (As of 6/30/2025)
Outstanding Shares: 39,348,313 (As of 6/30/2025)
Stock Exchange: EPA


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 13, 2026